The company markets products under multiple brands (Dynatron, Dynatron Solaris, Bird & Cronin, Hausmann, PROTEAM, and Mammoth) and sells through a network of independent dealers to orthopedists, physical therapists, chiropractors, athletic trainers, and hospitals. The company faces severe operational and financial distress following its Chapter 7 bankruptcy filing (January 2026), signaling the end of ongoing operations.
Cyborg Score Rationale
Revenue declined 15.8% year-over-year from $32.5M to $27.4M in fiscal 2025. Net profit margin was -39.8% in fiscal 2025. The company has a Piotroski F-Score of 3 out of 9, indicating weak financial health. Company is now in Chapter 7 liquidation (January 2026).
Top Insights
(January 2026) Company filed Chapter 7 bankruptcy petition; liquidation underway
(June 2024) Delisted from Nasdaq due to minimum bid price non-compliance; transitioned to OTC
Revenue contracted 15.8% in FY2025 to $27.4M; negative operating and net profit margins
Negative free cash flow and weak financial indicators signal operational distress
Named Competitors
DJO Global Products — Athletic bracing, orthopedic supports, rehabilitation equipment